These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35909535)

  • 1. Roles of osteocytes in phosphate metabolism.
    Michigami T
    Front Endocrinol (Lausanne); 2022; 13():967774. PubMed ID: 35909535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocytes and the pathogenesis of hypophosphatemic rickets.
    Yamazaki M; Michigami T
    Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-related skeletal changes and alterations in phosphate metabolism.
    Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
    Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.
    Carpenter KA; Davison R; Shakthivel S; Anderson KD; Ko FC; Ross RD
    Bone; 2022 Jan; 154():116201. PubMed ID: 34537437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
    FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of Fgf23 in Hyp mice.
    Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.
    Clinkenbeard EL; Cass TA; Ni P; Hum JM; Bellido T; Allen MR; White KE
    J Bone Miner Res; 2016 Jun; 31(6):1247-57. PubMed ID: 26792657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
    Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
    Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.
    Bergwitz C; Jüppner H
    Annu Rev Med; 2010; 61():91-104. PubMed ID: 20059333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine and endocrine functions of osteocytes.
    Michigami T
    Clin Pediatr Endocrinol; 2023; 32(1):1-10. PubMed ID: 36761497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.
    Miyagawa K; Yamazaki M; Kawai M; Nishino J; Koshimizu T; Ohata Y; Tachikawa K; Mikuni-Takagaki Y; Kogo M; Ozono K; Michigami T
    PLoS One; 2014; 9(4):e93840. PubMed ID: 24710520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23.
    Ito N; Prideaux M; Wijenayaka AR; Yang D; Ormsby RT; Bonewald LF; Atkins GJ
    Calcif Tissue Int; 2021 Jul; 109(1):66-76. PubMed ID: 33616712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.